138 related articles for article (PubMed ID: 34934763)
1. The impact of Model for End-Stage Liver Disease score on deceased donor liver transplant outcomes in low volume liver transplantation center: a retrospective and single-center study.
Lee DH; Park YH; Choi SW; Nam KH; Choi ST; Kim D
Ann Surg Treat Res; 2021 Dec; 101(6):360-367. PubMed ID: 34934763
[TBL] [Abstract][Full Text] [Related]
2. Impact of Model for End-Stage Liver Disease allocation system on outcomes of deceased donor liver transplantation: A single-center experience.
Park HS; Lee JM; Hong K; Han ES; Hong SK; Choi Y; Yi NJ; Lee KW; Suh KS
Ann Hepatobiliary Pancreat Surg; 2021 Aug; 25(3):336-341. PubMed ID: 34402433
[TBL] [Abstract][Full Text] [Related]
3. Changes in the allocation policy for deceased donor livers in Korea: perspectives from anesthesiologists.
Yoo SY; Kim GS
Anesth Pain Med (Seoul); 2021 Jan; 16(1):68-74. PubMed ID: 33486941
[TBL] [Abstract][Full Text] [Related]
4. Deceased donor liver transplantation under the Korean model for end-stage liver disease score-based liver allocation system: 2-year allocation results at a high-volume transplantation center.
Ha HS; Hong JJ; Kim IO; Lee SR; Lee AY; Ha TY; Song GW; Jung DH; Park GC; Ahn CS; Moon DB; Kim KH; Lee SG; Hwang S
Korean J Transplant; 2019 Dec; 33(4):112-117. PubMed ID: 35769978
[TBL] [Abstract][Full Text] [Related]
5. The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil.
Freitas AC; Itikawa WM; Kurogi AS; Stadnik LG; Parolin MB; Coelho JC
Arq Gastroenterol; 2010; 47(3):233-7. PubMed ID: 21140081
[TBL] [Abstract][Full Text] [Related]
6. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
[TBL] [Abstract][Full Text] [Related]
7. Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35.
Yun SO; Kim J; Rhu J; Choi GS; Joh JW
J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1293-1303. PubMed ID: 37799067
[TBL] [Abstract][Full Text] [Related]
8. Successful introduction of Model for End-stage Liver Disease scoring in deceased donor liver transplantation in Korea: analysis of first 1 year experience at a high-volume transplantation center.
Ha SM; Hwang S; Song GW; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kim KH; Kim DY; Namgung J; Kang WH; Kim SH; Jwa E; Kwon JH; Cho HD; Jung YK; Kang SH; Lee SG
Ann Hepatobiliary Pancreat Surg; 2017 Nov; 21(4):199-204. PubMed ID: 29264582
[TBL] [Abstract][Full Text] [Related]
9. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
[TBL] [Abstract][Full Text] [Related]
10. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
[TBL] [Abstract][Full Text] [Related]
11. Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience.
Iwamura S; Kaido T; Morita S; Miyachi Y; Yao S; Shirai H; Kobayashi A; Hamaguchi Y; Kamo N; Yagi S; Uemoto S
Hepatol Res; 2019 Jun; 49(6):687-694. PubMed ID: 30698359
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for hepatocellular carcinoma: the MELD impact.
Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
[TBL] [Abstract][Full Text] [Related]
13. Is renal replacement therapy necessary in deceased donor liver transplantation candidates with hepatorenal syndrome?: a 2-year experience at a high-volume center.
Park GC; Hwang S; Jung DH; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Yoon YI; Cho HD; Kwon JH; Chung YK; Kang SH; Jung IJ; Choi JU; Lee SG
Ann Surg Treat Res; 2020 Feb; 98(2):102-109. PubMed ID: 32051819
[TBL] [Abstract][Full Text] [Related]
14. Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience.
Li H; Li B; Wei Y; Yan L; Wen T; Xu M; Wang W; Yang J
PLoS One; 2013; 8(9):e74081. PubMed ID: 24040171
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Model for End Stage Liver Disease (MELD), MELD-Sodium (MELD-Na), and Child-Turcotte-Pugh (CTP) Score With Frailty in Patients With Hepatitis C Virus (HCV) Related Cirrhosis.
Panezai MQ; Taha Yaseen R; Lail G; Ali Khalid M; Ismail H; Majid Z; Kumar D; Shahzad S; Laeeq SM; Hassan Luck N
Cureus; 2023 Jun; 15(6):e40574. PubMed ID: 37465808
[TBL] [Abstract][Full Text] [Related]
16. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
[TBL] [Abstract][Full Text] [Related]
17. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
Wong TC; Fung JY; Pang HH; Leung CK; Li HF; Sin SL; Ma KW; She BW; Dai JW; Chan AC; Cheung TT; Lo CM
Hepatology; 2021 Jun; 73(6):2441-2454. PubMed ID: 33006772
[TBL] [Abstract][Full Text] [Related]
19. [The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term].
Boin Ide F; Leonardi MI; Udo EY; Sevá-Pereira T; Stucchi RS; Leonardi LS
Arq Gastroenterol; 2008; 45(4):275-83. PubMed ID: 19148354
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
Chok KSh; Chan SC; Fung JY; Cheung TT; Chan AC; Fan ST; Lo CM
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
